All lobbying filings
The McManus Group
The McManus Group filed a Q3 report for Infusion Providers Alliance on October 20, 2026, reporting $90,000 in lobbying income.
Lobbying for Infusion Providers Alliance · Association representing infusion drug providers.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$90,000
What the client paid this registrant for the period.
Client based in
Delaware
Lobbyists on this filing
1
-
JOHN MCMANUSPreviously held: Staff Director, W&M Health Subcommittee. LA, Rep. Bill Thomas.
Government bodies contacted
2
Lobbying activity
2
Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Advocating for access to and reimbursement for biosimilars. Issues related to vertical integration and white bagging. Issues related to patient access to products for asthma and allergies.
Bills named in this filing
1